|
Volumn 48, Issue 3, 2007, Pages 421-424
|
Incidence rate of injection-site granulomas resulting from the administration of Luteinizing hormone-releasing hormone analogues for the treatment of prostatic cancer
|
Author keywords
Goserelin acetate; Granulomas; Leuprorelin acetate; LH RH analogue; Prostatic neoplasms
|
Indexed keywords
GONADORELIN;
GOSERELIN;
LEUPRORELIN;
AGED;
ARTICLE;
CANCER HORMONE THERAPY;
CLINICAL ARTICLE;
CONSERVATIVE TREATMENT;
DRUG SUBSTITUTION;
DRUG WITHDRAWAL;
GRANULOMA;
HISTOPATHOLOGY;
HUMAN;
IMMUNOHISTOCHEMISTRY;
INCIDENCE;
INJECTION SITE INFLAMMATION;
MALE;
MEDICAL RECORD REVIEW;
PROSTATE CANCER;
RELAPSE;
SUBCUTANEOUS NODULE;
SURGICAL TECHNIQUE;
TREATMENT RESPONSE;
WOUND HEALING;
AGED;
AGED, 80 AND OVER;
ANTIGENS, CD;
ANTIGENS, CD3;
ANTIGENS, DIFFERENTIATION, MYELOMONOCYTIC;
ANTINEOPLASTIC AGENTS, HORMONAL;
GONADOTROPIN-RELEASING HORMONE;
GOSERELIN;
GRANULOMA;
HUMANS;
INJECTIONS, SUBCUTANEOUS;
LEUPROLIDE;
MALE;
PROSTATIC NEOPLASMS;
|
EID: 34447563621
PISSN: 05135796
EISSN: None
Source Type: Journal
DOI: 10.3349/ymj.2007.48.3.421 Document Type: Article |
Times cited : (16)
|
References (4)
|